应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BK4557 大麻股
休市中 06-12 16:00:00 EDT
219.19
-0.15
-0.07%
最高
220.87
最低
215.80
成交量
2,535万
今开
219.33
昨收
219.34
日振幅
2.31%
总市值
0.00
流通市值
0.00
总股本
0.00
成交额
2.90亿
换手率
--
流通股本
0.00
市净率
3.185784
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Catcher Predict:“Counter-Strike:Aurora Gaming 对战 Spirit (BO3) - IEM Cologne Major Stage 3” “O/U 2.5 场” 胜率飙升 61%
链捕手 · 06-13 03:00
Catcher Predict:“Counter-Strike:Aurora Gaming 对战 Spirit (BO3) - IEM Cologne Major Stage 3” “O/U 2.5 场” 胜率飙升 61%
Harrow Health重新上市Verkazia®(环孢素眼用乳剂)0.1%,满足儿童眼疾领域巨大未满足需求
美股速递 · 06-10
Harrow Health重新上市Verkazia®(环孢素眼用乳剂)0.1%,满足儿童眼疾领域巨大未满足需求
AIM ImmunoTech:根据SEC文件,售股股东拟发售及再售最多3130万股普通股
美股速递 · 06-09
AIM ImmunoTech:根据SEC文件,售股股东拟发售及再售最多3130万股普通股
AIM ImmunoTech公布中期积极临床进展:Ampligen®联合阿斯利康Imfinzi®治疗胰腺癌的二期研究
美股速递 · 06-08
AIM ImmunoTech公布中期积极临床进展:Ampligen®联合阿斯利康Imfinzi®治疗胰腺癌的二期研究
梯瓦制药Austedo®与Austedo XR®数据凸显迟发性运动障碍治疗与护理的长期进展
美股速递 · 06-08
梯瓦制药Austedo®与Austedo XR®数据凸显迟发性运动障碍治疗与护理的长期进展
Catcher Predict:“Dota 2:Aurora 对阵 LGD Gaming - BLAST Slam 季后赛” “比赛胜者” 胜率暴跌 18.5%
链捕手 · 06-07
Catcher Predict:“Dota 2:Aurora 对阵 LGD Gaming - BLAST Slam 季后赛” “比赛胜者” 胜率暴跌 18.5%
Catcher Predict:“Dota 2:Team Falcons 对阵 Aurora - BLAST Slam 季后赛” “比赛胜者” 胜率暴跌 17.5%
链捕手 · 06-06
Catcher Predict:“Dota 2:Team Falcons 对阵 Aurora - BLAST Slam 季后赛” “比赛胜者” 胜率暴跌 17.5%
Veru授予诺和诺德优先谈判权,涉及恩诺博沙姆与任何诺和诺德GLP-1产品的联合疗法
美股速递 · 06-04
Veru授予诺和诺德优先谈判权,涉及恩诺博沙姆与任何诺和诺德GLP-1产品的联合疗法
梯瓦制药拓展欧洲生物类似药版图 推出阿柏西普生物类似药Ahzantive®
美股速递 · 06-04
梯瓦制药拓展欧洲生物类似药版图 推出阿柏西普生物类似药Ahzantive®
Catcher Predict:“Dota 2:Aurora 对战 Team Yandex - BLAST Slam 季后赛” “比赛胜者” 胜率暴跌 29.5%
链捕手 · 06-04
Catcher Predict:“Dota 2:Aurora 对战 Team Yandex - BLAST Slam 季后赛” “比赛胜者” 胜率暴跌 29.5%
坎伯兰药业Ifetroban药物2a期试验达到安全性与耐受性主要终点
美股速递 · 06-02
坎伯兰药业Ifetroban药物2a期试验达到安全性与耐受性主要终点
坎伯兰药业与范德堡大学公布Ifetroban治疗高风险实体瘤的IIa期试验数据
美股速递 · 06-02
坎伯兰药业与范德堡大学公布Ifetroban治疗高风险实体瘤的IIa期试验数据
AIM ImmunoTech提前完成Duripanc二期试验患者入组关键节点,推动Ampligen迈向胰腺癌关键临床里程碑
美股速递 · 06-01
AIM ImmunoTech提前完成Duripanc二期试验患者入组关键节点,推动Ampligen迈向胰腺癌关键临床里程碑
Durect Corporation盘中异动 临近收盘急速上涨5.17%
市场透视 · 2025-03-11
Durect Corporation盘中异动 临近收盘急速上涨5.17%
Growgeneration Corp.盘中异动 急速下挫5.26%
市场透视 · 2025-03-11
Growgeneration Corp.盘中异动 急速下挫5.26%
Greenlane Holdings, Inc.盘中异动 大幅上涨5.32%报0.572美元
市场透视 · 2025-03-11
Greenlane Holdings, Inc.盘中异动 大幅上涨5.32%报0.572美元
梯瓦制药盘中异动 急速下跌5.01%
市场透视 · 2025-03-10
梯瓦制药盘中异动 急速下跌5.01%
Harrow, Inc.盘中异动 快速下挫5.09%报23.14美元
市场透视 · 2025-03-10
Harrow, Inc.盘中异动 快速下挫5.09%报23.14美元
Aurora Innovation Inc C/Wts 03/11/2026 (To Pur Com)盘中异动 股价大跌7.47%报1.43美元
市场透视 · 2025-03-10
Aurora Innovation Inc C/Wts 03/11/2026 (To Pur Com)盘中异动 股价大跌7.47%报1.43美元
坎伯兰药业盘中异动 早盘股价大跌5.34%报6.03美元
市场透视 · 2025-03-10
坎伯兰药业盘中异动 早盘股价大跌5.34%报6.03美元
暂无数据
公司概况
公司名称:
大麻股
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"BK4557","market":"US","secType":"PLATE","nameCN":"大麻股","latestPrice":219.19,"timestamp":1781294399999,"preClose":219.34158,"halted":0,"volume":25347684,"delay":0,"changeRate":-0.000691,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-0.151581,"latestTime":"06-12 16:00:00 EDT","open":219.33095,"high":220.87236,"low":215.80412,"amount":290105456.357516,"amplitude":0.023107,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1781510400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.185784,"peRate":223.162181,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4557/tweets","defaultTab":"tweets","newsList":[{"id":"2643730297","title":"Catcher Predict:“Counter-Strike:Aurora Gaming 对战 Spirit (BO3) - IEM Cologne Major Stage 3” “O/U 2.5 场” 胜率飙升 61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643730297","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643730297?lang=zh_cn&edition=full","pubTime":"2026-06-13 03:00","pubTimestamp":1781290808,"startTime":"0","endTime":"0","summary":" 据 Catcher Predict 监测,预测市场 Polymarket 上“Counter-Strike:Aurora Gaming 对战 Spirit (BO3) - IEM Cologne Major Stage 3”事件中,子市场“O/U 2.5 场”的“Over”选项胜率发生剧烈波动,由 1 小时前的 34% 飙升至当前的 95%(波动幅度达 61%)。请注意相关突发消息影响。 ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2271109","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ACB","MSOS","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162693514","title":"Harrow Health重新上市Verkazia®(环孢素眼用乳剂)0.1%,满足儿童眼疾领域巨大未满足需求","url":"https://stock-news.laohu8.com/highlight/detail?id=1162693514","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162693514?lang=zh_cn&edition=full","pubTime":"2026-06-10 19:02","pubTimestamp":1781089335,"startTime":"0","endTime":"0","summary":"Harrow Health公司已重新推出Verkazia®(环孢素眼用乳剂)0.1%,专门用于治疗春季角结膜炎。这一举措旨在应对儿童眼科护理中长期存在的显著未满足需求,为患有这种严重过敏性眼病的儿童患者提供新的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4007","HROW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115821813","title":"AIM ImmunoTech:根据SEC文件,售股股东拟发售及再售最多3130万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1115821813","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115821813?lang=zh_cn&edition=full","pubTime":"2026-06-09 04:09","pubTimestamp":1780949356,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会(SEC)的文件披露,AIM ImmunoTech Inc.的售股股东计划发售及再售公司普通股,总量最高可达3130万股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4557","AIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111192858","title":"AIM ImmunoTech公布中期积极临床进展:Ampligen®联合阿斯利康Imfinzi®治疗胰腺癌的二期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1111192858","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111192858?lang=zh_cn&edition=full","pubTime":"2026-06-08 20:33","pubTimestamp":1780921999,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech公司公布了其针对胰腺癌治疗的二期临床研究的中期积极进展。该研究旨在评估其药物Ampligen与阿斯利康的Imfinzi联合疗法的效果。此次公布的中期数据展现了令人鼓舞的临床发展态势。研究探索了这种联合用药方案在治疗胰腺癌患者中的潜力。胰腺癌作为一种侵袭性强、治疗选择有限的恶性肿瘤,新的有效疗法备受期待。后续的完整临床数据将为进一步评估该联合疗法的安全性与有效性提供关键依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIM","BK4557","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188750222","title":"梯瓦制药Austedo®与Austedo XR®数据凸显迟发性运动障碍治疗与护理的长期进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1188750222","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188750222?lang=zh_cn&edition=full","pubTime":"2026-06-08 20:01","pubTimestamp":1780920082,"startTime":"0","endTime":"0","summary":"梯瓦制药(Teva Pharmaceutical)公布的数据显示,其Austedo®(氘代丁苯那嗪)片剂与Austedo XR®(氘代丁苯那嗪)缓释片剂,在迟发性运动障碍的治疗与护理方面取得了显著的长期进展。这些数据进一步证实了该药物在管理这一挑战性运动障碍中的持续疗效与价值,为患者提供了更稳定、持久的症状控制方案,有望改善长期治疗结局与生活质量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4596","BK4559","BK4007","BK4566","TEVA","BK4584","BK4585","LU1983299246.USD","BK4588","BK4557","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641122903","title":"Catcher Predict:“Dota 2:Aurora 对阵 LGD Gaming - BLAST Slam 季后赛” “比赛胜者” 胜率暴跌 18.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641122903","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641122903?lang=zh_cn&edition=full","pubTime":"2026-06-07 01:00","pubTimestamp":1780765210,"startTime":"0","endTime":"0","summary":" 据 Catcher Predict 监测,预测市场 Polymarket 上“Dota 2:Aurora 对阵 LGD Gaming - BLAST Slam 季后赛”事件中,子市场“比赛胜者”的“Aurora”选项胜率发生剧烈波动,由 1 小时前的 75.5% 暴跌至当前的 57%(波动幅度达 18.5%)。请注意相关突发消息影响。 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2269758","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACB","MSOS","SLAMU","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641144554","title":"Catcher Predict:“Dota 2:Team Falcons 对阵 Aurora - BLAST Slam 季后赛” “比赛胜者” 胜率暴跌 17.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641144554","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641144554?lang=zh_cn&edition=full","pubTime":"2026-06-06 01:00","pubTimestamp":1780678808,"startTime":"0","endTime":"0","summary":" 据 Catcher Predict 监测,预测市场 Polymarket 上“Dota 2:Team Falcons 对阵 Aurora - BLAST Slam 季后赛”事件中,子市场“比赛胜者”的“Team Falcons”选项胜率发生剧烈波动,由 1 小时前的 57% 暴跌至当前的 39.5%(波动幅度达 17.5%)。请注意相关突发消息影响。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2269591","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSOS","ACB","SLAMU","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110985415","title":"Veru授予诺和诺德优先谈判权,涉及恩诺博沙姆与任何诺和诺德GLP-1产品的联合疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1110985415","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110985415?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:34","pubTimestamp":1780576456,"startTime":"0","endTime":"0","summary":"Veru Inc. 已授予诺和诺德一项优先谈判权,内容涉及将其药物恩诺博沙姆与诺和诺德旗下任何GLP-1产品相结合的联合疗法开发。此项协议为两家公司在代谢疾病治疗领域的潜在合作奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4584","VERU","BK4557","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121184893","title":"梯瓦制药拓展欧洲生物类似药版图 推出阿柏西普生物类似药Ahzantive®","url":"https://stock-news.laohu8.com/highlight/detail?id=1121184893","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121184893?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:32","pubTimestamp":1780576370,"startTime":"0","endTime":"0","summary":"梯瓦制药正通过在欧洲市场推出阿柏西普(Aflibercept)生物类似药Ahzantive®,进一步扩大其在该地区的生物类似药产品组合。该药物是眼科重磅药物Eylea®的生物类似药版本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4596","BK4584","BK4007","LU1983299246.USD","BK4566","TEVA","BK4557","BK4588","BK4559","LU2324357040.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640544631","title":"Catcher Predict:“Dota 2:Aurora 对战 Team Yandex - BLAST Slam 季后赛” “比赛胜者” 胜率暴跌 29.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640544631","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640544631?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:15","pubTimestamp":1780571709,"startTime":"0","endTime":"0","summary":" 据 Catcher Predict 监测,预测市场 Polymarket 上“Dota 2:Aurora 对战 Team Yandex - BLAST Slam 季后赛”事件中,子市场“比赛胜者”的“Aurora”选项胜率发生剧烈波动,由 1 小时前的 57% 暴跌至当前的 27.5%(波动幅度达 29.5%)。请注意相关突发消息影响。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2269221","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MSOS","ACB","SLAMU","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184352492","title":"坎伯兰药业Ifetroban药物2a期试验达到安全性与耐受性主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1184352492","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184352492?lang=zh_cn&edition=full","pubTime":"2026-06-02 21:12","pubTimestamp":1780405937,"startTime":"0","endTime":"0","summary":"坎伯兰药业宣布,其药物Ifetroban的2a期临床试验已成功达到安全性与耐受性的主要终点。该研究结果标志着该候选药物在临床开发中取得了积极进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4007","CPIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113324670","title":"坎伯兰药业与范德堡大学公布Ifetroban治疗高风险实体瘤的IIa期试验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1113324670","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113324670?lang=zh_cn&edition=full","pubTime":"2026-06-02 21:11","pubTimestamp":1780405883,"startTime":"0","endTime":"0","summary":"坎伯兰药业与范德堡大学联合宣布了其候选药物Ifetroban在治疗高风险实体瘤患者中的IIa期临床试验数据。这项研究旨在评估该药物的安全性与初步疗效,为后续的临床开发提供关键依据。试验结果显示了积极的信号,为针对这类难治性肿瘤的新疗法开发带来了希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CPIX","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177685141","title":"AIM ImmunoTech提前完成Duripanc二期试验患者入组关键节点,推动Ampligen迈向胰腺癌关键临床里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1177685141","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177685141?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:59","pubTimestamp":1780318759,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech公司宣布,其针对胰腺癌的Duripanc二期临床试验已提前完成患者入组目标。这一进展标志着公司核心候选药物Ampligen在攻克这一难治性癌症的临床开发道路上,迈出了至关重要的一步。该里程碑的达成,为后续评估Ampligen联合标准疗法治疗胰腺导管腺癌的有效性与安全性铺平了道路,加速了其向关键临床节点推进的进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4139","AIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518788366","title":"Durect Corporation盘中异动 临近收盘急速上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518788366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518788366?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:49","pubTimestamp":1741636170,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时49分,Durect Corporation股票出现波动,股价急速拉升5.17%。截至发稿,该股报0.805美元/股,成交量16.1738万股,换手率0.52%,振幅10.44%。Durect Corporation股票所在的制药行业中,整体跌幅为2.66%。其相关个股中,Sonoma Pharmaceuticals, Inc.、Medicus Pharma Ltd.、Sunshine Biopharma Inc C/Wts 涨幅较大,Sonoma Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃,换手率分别为2044.09%、38.35%、29.50%,振幅较大的相关个股有Sonoma Pharmaceuticals, Inc.、Alvotech C/Wts 、Scilex Holding Company C/Wts 10/11/2027 ,振幅分别为60.30%、41.21%、35.91%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311034930a26ab6c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311034930a26ab6c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4007","DRRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518720629","title":"Growgeneration Corp.盘中异动 急速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518720629?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:48","pubTimestamp":1741628903,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时48分,Growgeneration Corp.股票出现波动,股价大幅下跌5.26%。截至发稿,该股报1.08美元/股,成交量24.2291万股,换手率0.41%,振幅4.39%。Growgeneration Corp.股票所在的零售行业中,整体涨幅为1.74%。Growgeneration Corp.公司简介:GrowGeneration Corp 拥有并经营专业零售水培和有机园艺商店。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101482398a2cfda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101482398a2cfda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRWG","BK4083","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518203722","title":"Greenlane Holdings, Inc.盘中异动 大幅上涨5.32%报0.572美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518203722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518203722?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:58","pubTimestamp":1741625909,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时58分,Greenlane Holdings, Inc.股票出现波动,股价快速上涨5.32%。Greenlane Holdings, Inc.股票所在的烟草行业中,整体涨幅为0.03%。其相关个股中,奥驰亚、Greenlane Holdings, Inc.、环球烟草涨幅较大,22Nd Century Group, Inc、Greenlane Holdings, Inc.、Kaival Brands Innovations Group, Inc.较为活跃,换手率分别为1.70%、1.18%、1.00%,振幅较大的相关个股有Kaival Brands Innovations Group, Inc.、22Nd Century Group, Inc、Greenlane Holdings, Inc.,振幅分别为11.49%、7.65%、7.62%。Greenlane Holdings, Inc.公司简介:Greenlane Holdings Inc是美国汽化产品和消费配件的分销商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100582996405fd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031100582996405fd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNLN","BK4557","BK4159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518274873","title":"梯瓦制药盘中异动 急速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518274873?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:09","pubTimestamp":1741619345,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时09分,梯瓦制药股票出现波动,股价急速跳水5.01%。梯瓦制药股票所在的制药行业中,整体跌幅为1.97%。梯瓦制药公司简介:梯瓦制药工业有限公司总部位于以色列,是世界领先的仿制药制造商。梯瓦一半的销售额来自北美,在美国仿制药处方总数中所占的比例很高,为个位数。梯瓦还销售活性药物成分,提供合同制造服务,并拥有美国仿制药和特种药分销商Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230905abf32054&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230905abf32054&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4596","BK4566","TEVA","BK4584","BK4585","BK4007","BK4559","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518464227","title":"Harrow, Inc.盘中异动 快速下挫5.09%报23.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518464227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518464227?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:57","pubTimestamp":1741615071,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时57分,Harrow, Inc.股票出现波动,股价急速下挫5.09%。截至发稿,该股报23.14美元/股,成交量4.036万股,换手率0.11%,振幅2.40%。Harrow, Inc.股票所在的制药行业中,整体跌幅为1.64%。Harrow, Inc.公司简介:Harrow Inc 是一家眼科制药公司,致力于为美国市场发现、开发和商业化眼科药品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021575198a2a3de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021575198a2a3de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HROW","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518273239","title":"Aurora Innovation Inc C/Wts 03/11/2026 (To Pur Com)盘中异动 股价大跌7.47%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518273239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518273239?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:50","pubTimestamp":1741614606,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时50分,Aurora Innovation Inc C/Wts 03/11/2026 股票出现波动,股价大幅跳水7.47%。截至发稿,该股报1.43美元/股,成交量1788股,换手率0.01%,振幅7.47%。Aurora Innovation Inc C/Wts 03/11/2026 股票所在的信息科技服务行业中,整体跌幅为0.60%。Aurora Innovation Inc C/Wts 03/11/2026 公司简介:Aurora Innovation Inc提供安全、快速和广泛的自动驾驶技术。Aurora Driver 是一套旨在操作多种车辆类型的自动驾驶系统,从货运卡车到打车服务的乘用车。它支撑着 Aurora Horizon 和 Aurora Connect,这两款为货运和打车服务提供的驾驶服务产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215006a26a2bf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215006a26a2bf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AUR","BK4023","BK4137","ACB","AUROW","BK4557","BK4007"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2518240662","title":"坎伯兰药业盘中异动 早盘股价大跌5.34%报6.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518240662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518240662?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:37","pubTimestamp":1741613843,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时37分,坎伯兰药业股票出现波动,股价急速下挫5.34%。截至发稿,该股报6.03美元/股,成交量1.1541万股,换手率0.08%,振幅3.69%。坎伯兰药业股票所在的制药行业中,整体跌幅为0.72%。坎伯兰药业公司简介:坎伯兰药业有限公司 是一家专注于获取、开发和商业化品牌处方药物的专业制药公司。公司的收入来源于 FDA 批准的药品品牌的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021372398a29e3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021372398a29e3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CPIX","BK4557"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0057},{"period":"1month","weight":-0.0008},{"period":"3month","weight":0.12},{"period":"6month","weight":0.088},{"period":"1year","weight":0.2286},{"period":"ytd","weight":0.0877}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"大麻股","nameEN":"BK4557"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"大麻股(BK4557)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供大麻股(BK4557)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"大麻股,BK4557,大麻股股票,大麻股股票老虎,大麻股股票老虎国际,大麻股行情,大麻股股票行情,大麻股股价,大麻股股市,大麻股股票价格,大麻股股票交易,大麻股股票购买,大麻股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"大麻股(BK4557)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供大麻股(BK4557)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}